286 related articles for article (PubMed ID: 16871129)
1. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
Weisler RH; Biederman J; Spencer TJ; Wilens TE; Faraone SV; Chrisman AK; Read SC; Tulloch SJ
CNS Spectr; 2006 Aug; 11(8):625-39. PubMed ID: 16871129
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
4. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study.
Spencer TJ; Adler LA; Weisler RH; Youcha SH
J Clin Psychiatry; 2008 Sep; 69(9):1437-48. PubMed ID: 19012813
[TBL] [Abstract][Full Text] [Related]
5. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
Wigal T; Brams M; Frick G; Yan B; Madhoo M
Postgrad Med; 2018 Jun; 130(5):481-493. PubMed ID: 29809075
[TBL] [Abstract][Full Text] [Related]
7. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
Wilens TE; Zusman RM; Hammerness PG; Podolski A; Whitley J; Spencer TJ; Gignac M; Biederman J
J Clin Psychiatry; 2006 May; 67(5):696-702. PubMed ID: 16841618
[TBL] [Abstract][Full Text] [Related]
8. An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.
Goodman DW; Ginsberg L; Weisler RH; Cutler AJ; Hodgkins P
CNS Spectr; 2005 Dec; 10(12 Suppl 20):26-34. PubMed ID: 16344838
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
[TBL] [Abstract][Full Text] [Related]
10. Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment.
Wigal T; Childress A; Frick G; Yan B; Wigal S; Madhoo M
Postgrad Med; 2018 Jan; 130(1):111-121. PubMed ID: 29087231
[TBL] [Abstract][Full Text] [Related]
11. Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder.
Surman CBH; Robertson B; Chen J; Cortese S
CNS Drugs; 2019 Jul; 33(7):695-706. PubMed ID: 31228031
[TBL] [Abstract][Full Text] [Related]
12. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
Weisler RH; Biederman J; Spencer TJ; Wilens TE
CNS Spectr; 2005 Dec; 10(12 Suppl 20):35-43. PubMed ID: 16344839
[TBL] [Abstract][Full Text] [Related]
13. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
Ambrosini PJ; Sallee FR; Lopez FA; Shi L; Michaels MA;
Curr Med Res Opin; 2006 Feb; 22(2):427-40. PubMed ID: 16466615
[TBL] [Abstract][Full Text] [Related]
14. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
Mattingly G; Arnold V; Yan B; Yu M; Robertson B
J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):549-557. PubMed ID: 33185468
[No Abstract] [Full Text] [Related]
15. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
[TBL] [Abstract][Full Text] [Related]
16. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
Brams M; Childress AC; Greenbaum M; Yu M; Yan B; Jaffee M; Robertson B
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):19-28. PubMed ID: 28816509
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD.
Wigal S; Lopez F; Frick G; Yan B; Robertson B; Madhoo M
Postgrad Med; 2019 Apr; 131(3):212-224. PubMed ID: 30681017
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit/hyperactivity disorder.
Martin PT; Corcoran M; Zhang P; Katic A
Clin Drug Investig; 2014 Feb; 34(2):147-57. PubMed ID: 24297663
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.
Biederman J; Spencer TJ; Wilens TE; Weisler RH; Read SC; Tulloch SJ;
CNS Spectr; 2005 Dec; 10(12 Suppl 20):16-25. PubMed ID: 16344837
[TBL] [Abstract][Full Text] [Related]
20.
Adler LA; Robertson B; Chen J; Sarkis E
J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):427-438. PubMed ID: 32423239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
